HK1249438A1 - 用於緩解尿頻的緩釋製劑及其使用方法 - Google Patents
用於緩解尿頻的緩釋製劑及其使用方法Info
- Publication number
- HK1249438A1 HK1249438A1 HK18109111.5A HK18109111A HK1249438A1 HK 1249438 A1 HK1249438 A1 HK 1249438A1 HK 18109111 A HK18109111 A HK 18109111A HK 1249438 A1 HK1249438 A1 HK 1249438A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- urination
- frequency
- reducing
- release formulation
- delayed release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/343,349 US20120141554A1 (en) | 2010-07-08 | 2012-01-04 | Delayed release formulation for reducing the frequency of urination and method of use thereof |
EP12150405.4A EP2612661B1 (en) | 2012-01-04 | 2012-01-06 | Delayed release formulation for reducing the frequency of urination and method of use thereof |
US13/423,949 US8236856B2 (en) | 2010-07-08 | 2012-03-19 | Delayed release formulation for reducing the frequency of urination and method of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1249438A1 true HK1249438A1 (zh) | 2018-11-02 |
Family
ID=48714361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18109111.5A HK1249438A1 (zh) | 2012-01-04 | 2018-07-13 | 用於緩解尿頻的緩釋製劑及其使用方法 |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN103191430A (zh) |
HK (1) | HK1249438A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170049613A (ko) * | 2014-09-24 | 2017-05-10 | 웰즐리 파마슈티컬스 엘엘씨 | 방광경련을 감소시키기 위한 약학적 제형과 이의 사용법 |
RU2018111401A (ru) * | 2015-09-01 | 2019-10-02 | УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Составы с отсроченным высвобождением, способы их получения и применения |
WO2017039832A1 (en) * | 2015-09-01 | 2017-03-09 | Wellesley Pharmaceuticals, Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
AU2016331879A1 (en) * | 2015-09-30 | 2018-05-17 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003211078A1 (en) * | 2002-02-19 | 2003-09-09 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
CN101648017A (zh) * | 2008-08-12 | 2010-02-17 | 许洁 | 用于治疗泌尿生殖系统及下尿路疾病的联合药物组合物 |
-
2012
- 2012-05-21 CN CN2012101596060A patent/CN103191430A/zh active Pending
- 2012-05-21 CN CN201711114542.1A patent/CN107648212A/zh active Pending
-
2018
- 2018-07-13 HK HK18109111.5A patent/HK1249438A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN107648212A (zh) | 2018-02-02 |
CN103191430A (zh) | 2013-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274404A (en) | Body expandable device and method for use | |
HK1200690A1 (zh) | 可膨脹體裝置和使用方法 | |
PL2683731T3 (pl) | C4-monometylowe pochodne triterpenoidów i sposoby ich zastosowania | |
ZA201403762B (en) | Delayed-release formulation for reducing the frequency of urination and method of use thereof | |
EP2838444A4 (en) | EXPANDABLE OCCLUSION DEVICES AND METHODS OF USE | |
EP2800528A4 (en) | DEABLABLE OCCLUSION DEVICES AND USE METHOD THEREFOR | |
HK1243921A1 (zh) | 用於緩解尿頻的延長釋放製劑及其使用方法 | |
IL232715A0 (en) | The delayed-release composition for reducing the frequency of urination and a method for using it | |
HK1249438A1 (zh) | 用於緩解尿頻的緩釋製劑及其使用方法 | |
IL261232A (en) | A pharmaceutical formulation for reducing urinary frequency and a method for its use | |
GB201419581D0 (en) | Expandable reamers and methods of using expandable reamers | |
IL221043A0 (en) | Modified release formulation and methods of use | |
HK1248549A1 (zh) | 用於緩解尿頻的延長釋放製劑及其使用方法 | |
IL238934A0 (en) | Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use | |
EP2699539A4 (en) | CYCLOPROPYLATED DERIVATIVES AND METHODS OF USE | |
EP2525660A4 (en) | FORMULATION WITH MODIFIED RELEASE AND USE METHOD | |
PL391702A1 (pl) | Sposób otrzymywania 5-hydroksykreatyniny i N-metyloguanidyny |